An image of pancreatic cancer – credit, PLOS ONE / DOI10.1371journal.pone.0150338 / CC 4.0. Int Researchers at Johns Hopkins report that an experimental drug targeting one of the most common genetic…
Good News Network
Experimental Drug Generates Immune Response Against Pancreatic Cancer in People at High Risk
Read full article at Good News Network
Disclaimer: This article summary is sourced from Good News Network. HealthRankings provides this for informational purposes only. Always consult a qualified healthcare provider before making medical decisions.
More health news
New York Post
‘Exercise pill’ that may reduce appetite and mimic physical activity clears first human test
Yesterday
Al Jazeera English
Ebola outbreak ‘growing faster, wider’ as DRC death toll passes 2,500: UN
Yesterday
BBC News
Ebola in DR Congo: Vaccine trial to start as WHO warns about speed of infections
Yesterday:max_bytes(150000):strip_icc()/VWH-peanuts-vs-popcorn-7f4685b6b8e14bc4ae755d26c6da8ed2.jpeg)
Verywellhealth.com